Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FIBRINOGEN study in CABG blood samples
NL-OMON34478Recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Dec 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of Fibrinogen human, recombinant human fibrinogen Aα610 and recombinant human fibrinogen Aα847 in coagulation defects and coagulopathy (4 arms), sponsored by Leiden University Medical Center. Primary endpoints: ROTEM clotting time, ROTEM clot formation time and 8 more. Started Dec 2010; status: recruiting.
02
Drugs
Fibrinogen humanrecombinant human fibrinogen Aα610recombinant human fibrinogen Aα847
03
Conditions
coagulation defectscoagulopathy
Beyond the preview
Go deeper on NL-OMON34478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34478.